✦ LIBER ✦

Prostate cancer: are new prognostic markers on the horizon?

✍ Scribed by Lijovic, M; Fabiani, M E; Bader, J; Frauman, A G

Book ID: 110073207
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 70 KB
Volume: 3
Category: Article
ISSN: 1365-7852
DOI: 10.1038/sj.pcan.4500408

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Applications for new superconductors are

Applications for new superconductors are on the horizon

✍ Lindley, David 📂 Article 📅 1987 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

Secondary hormonal therapy for prostate

Secondary hormonal therapy for prostate cancer: what lies on the horizon?

✍ Nima Sharifi; William L. Dahut; William D. Figg 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Quantitative glycohistochemistry defines

Quantitative glycohistochemistry defines new prognostic markers for cancers of the oral cavity

✍ Sven Saussez; Hadelin Marchant; Nathalie Nagy; Christine Decaestecker; Sergio Ha 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

## Background: Histopathologic grading and clinical staging cannot provide a precise prognosis of oral cavity cancer patients. the use of glycohistochemical markers may improve the level of prognostic accuracy of such conventional classification systems. ## Methods: Computer-assisted microscopy w

Markers of prostate region-specific epit

Markers of prostate region-specific epithelial identity define anatomical locations in the mouse prostate that are molecularly similar to human prostate cancers

✍ Joshua L. Thielen; Katherine G. Volzing; Lara S. Collier; Laura E. Green; David 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 937 KB

Antibodies against the cancer-testis ant

Antibodies against the cancer-testis antigen CTSP-1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical-recurrence

✍ Raphael B. Parmigiani; Fabiana Bettoni; Daniela M Grosso; Ademar Lopes; Isabela 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 221 KB

## Abstract Cancer‐testis (CT) antigens are immunogenic proteins expressed in normal gametogenic tissues and in different types of tumors. CTSP‐1 is a CT antigen frequently expressed in prostate tumors, and capable of eliciting humoral response in prostate cancer patients. Here, we analyzed the pre

C-reactive protein as a prognostic marke

C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer : Results from the ASCENT trial

✍ Tomasz M. Beer; Alshad S. Lalani; Stella Lee; Motomi Mori; Kristine M. Eilers; J 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

## Abstract ## BACKGROUND. Studies of cancer risk and molecular carcinogenesis suggest a role for inflammation in cancer development and progression. The authors sought to determine whether specific blood proteins associated with inflammation predict for outcomes in men with metastatic androgen‐in